Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Ulrik Lassen provides an overview of the frequency and distribution of NTRK gene fusions in rare and common human cancers, in particular very high occurrences in some rare cancers where their detection is also a part of diagnostic work-up and a low rate in some frequent cancers.
Recent approvals of effective drugs might lead to the change in molecular testing mode: switching from time consuming and costly individual gene fusions detection to NGS.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
